Navigation Links
Greenberg Traurig’s Evan Holden Speaks at National Academy of Sciences Roundtable on Biomedical Engineering Materials Applications
Date:3/27/2019

Evan Holden, a shareholder in the Atlanta office of global law firm Greenberg Traurig, LLP, was a panelist at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), March 25 in Washington D.C. at NAS’ Keck Center. Holden, a member of the firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice, addressed, “Medical Device Liability—How Do We Prevent Claims from the Get-Go?”

NAS is a private, nonprofit organization of the country’s leading researchers. The BEMA Roundtable brings together government officials, industry representatives, academics, and other leaders for discussions of issues related to research, development, applications, and regulation of biomedical materials and devices.  Holden’s panel discussed product liability law applicable to manufacturers of medical devices and strategies for companies to minimize risk and avoid litigation.

Holden represents life science companies, medical device manufacturers, global product manufacturers and Fortune 500 companies in the pharmaceutical and medical device industries. With over a decade of experience in products liability litigation, Holden is on the national counsel teams for some of the world’s largest medical device manufacturers and pharmaceutical companies. He also counsels clients on compliance matters, risk assessment, product recalls, and reporting activities governed by the Consumer Product Safety Commission, FDA, and other federal and state regulatory bodies. Holden is a core member of the team that was named American Lawyer’s 2018 “Product Liability Litigation Department of the Year” and 2018 “Georgia Regional Litigation Department of the Year.”

About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice: The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2018 “Litigation Department of the Year” for Product Liability from The American Lawyer; 2017 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2017 “Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and being named the Products Liability/Mass Torts Litigation Department of the Year by The Daily Report in 2013 and 2015 - 2017.  In addition, Greenberg Traurig is recognized as a “Product Liability Litigation Standout” in the BTI Litigation Outlook 2018 published by BTI Consulting Group.

About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law

Read the full story at https://www.prweb.com/releases/greenberg_traurigs_evan_holden_speaks_at_national_academy_of_sciences_roundtable_on_biomedical_engineering_materials_applications/prweb16198000.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Greenberg Traurig Hosts Boston Healthcare Drinks and Discussion on China Biopharma Industry
2. TGen President Dr. Jeffrey Trent speaks at Brookings Institution biomedical conference
3. Autism Speaks awards nearly $2.7 million for new research projects
4. Autism Speaks announces 2014 Weatherstone Predoctoral Fellows
5. Autism Speaks to sequence worlds largest collection of autism genomes
6. Autism speaks announces Meixner Postdoctoral Fellowships in translational research
7. Air pollution diminishing air quality at Devils Postpile National Monument
8. 2013 AAPS National Biotechnology Conference returns to San Diego
9. National survey highlights perceived importance of dietary protein to prevent weight gain
10. Carnegies Greg Asner elected to National Academy of Sciences
11. AAPS announces 2013 National Biotechnology Conference award winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2019)... ... April 02, 2019 , ... Researchers from Ambry Genetics ... RNA genetic testing (RGT), as a supplement to DNA genetic testing, improves variant ... poster, is one of 13 presentations at the 2019 American College of Medical ...
(Date:4/1/2019)... ... April 01, 2019 , ... ... Characterizing Skin Related Conditions” by the US Patent and Trademark Office on January ... an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:3/29/2019)... ... ... In the development of biosimilars, the broad definition of the similarity concept in ... several manufacturers have been successful and numerous follow-on biologics are approved in the US ... analytical similarity is achieved in biosimilars based on recently approved products in the US. ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... Utah and BOSTON (PRWEB) , ... April 08, ... ... delivering cloud-based enterprise-class unified communications and collaboration solutions, announced today the launch of ... integration to an unprecedented range of business and contact-orientated applications while using CT ...
(Date:4/8/2019)... (PRWEB) , ... April 09, 2019 , ... ... disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen ... of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches ...
(Date:4/4/2019)... (PRWEB) , ... April 03, 2019 , ... ... together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference ... offers insights into the industry’s challenges and opportunities with high-level panels and discussions ...
(Date:3/27/2019)... ... ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma has ... Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo to ...
Breaking Biology Technology: